Corium, LLC

Corium, LLC, a commercial-stage biopharmaceutical company, develops and commercializes central nervous system (CNS) therapies and pharmaceutical products. The company’s products include AZSTARYS, a central nervous system (CNS) stimulant prescription medicine for the treatment of attention deficit hyperactivity disorder (ADHD), and ADLARITY, a donepezil transdermal system for the treatment of mild, moderate, or severe dementia of the Alzheimer’s type. The company was formerly known as Corium International, Inc. and changed its name to Corium, LLC in March 2019. Corium, LLC was founded in 1999 and is based in Grand Rapids, Michigan with an additional location in Boston, Massachusetts.